Catalyst Wire Dossier Catalyst Wire Dossier

Lynparza (Olaparib)

Olaparib · AstraZeneca
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Lynparza (Olaparib), covering 2023-04-20 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Olaparib in Recurrent IDH-mutant Glioma [Phase 2]

See pricing